An immuno-histochemical analysis for the expression of β3-AR has been assessed in different cutaneous human melanocytic lesions including common and atypical nevi, in situ primary melanoma, superficial spreading melanoma, nodular melanoma, cutaneous, and lymph-nodal metastatic melanoma. Here, ADRB3 is linked to melanoma.